Join our daily newsletter At The Bell to receive exclusive market insights
- An investigation is underway after two men in NSW died after being vaccinated against COVID-19
- The medicines watchdog will examine whether the coronavirus vaccine played a part in two men’s deaths,
- One of the men, aged in his 50s, died in hospital in Tamworth, while the other man, aged in his 70s, died in hospital in Sydney
- It’s not known what vaccines the men took, or whether or not they had underlying health conditions
- However, it’s believed both men died after suffering blood clots, prompting the Therapeutic Goods Administration (TGA) to review the cases
- No link between the vaccines and their deaths has been established, however, the TGA has linked six cases of clots to the AstraZeneca vaccine
An investigation is underway after two men in NSW died after being vaccinated against COVID-19.
Australia’s medicines watchdog will examine both cases to determine whether the coronavirus vaccine played a part in either of the men’s deaths.
One of the men, aged in his 50s, died in hospital in Tamworth while the other man, aged in his 70s, died in hospital in Sydney.
In a statement to the ABC, the Therapeutic Goods Administration (TGA) confirmed it was reviewing the incidents.
“All reports to the TGA of death following vaccination are reviewed to assess the likelihood that the vaccine contributed to the event or medical condition that led to a fatal outcome,” the TGA said.
“The reporting of an adverse event to the TGA post-vaccination does not mean the event was caused by the vaccination,” the agency explained.
The TGA hasn’t revealed what vaccines the men took, or whether or not they had underlying health conditions.
However, it’s reported both men died after suffering blood clots in the weeks following their COVID-19 vaccinations.
As of Wednesday, the TGA had confirmed six cases where clots occurred in Australian patients after they were administered the AstraZeneca vaccine.
“A total of six cases of thrombosis with thrombocytopenia syndrome have been identified in Australia, with affected patients being 35 to 80 years old,” the TGA explained.
Around two million COVID-19 vaccines have been administered in Australia since March, according to the latest government figures.
